Skip to Content

News

China approves Sinopharm Covid-19 vaccine, promises free jabs for all citizens

China approved its first homegrown coronavirus vaccine for general public use on Thursday, with officials promising to provide the general public with free inoculations. The approval comes a day after its manufacturer, state-owned pharmaceutical giant Sinopharm, said the vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials. Though no detailed efficacy data

Continue Reading
U.S. Sen. Josh Hawley

Sen. Hawley says he will object during Electoral College vote certification

COLUMBIA, Mo. (KMIZ) Missouri’s junior senator said Wednesday that he will challenge the Electoral College vote naming Democrat Joe Biden president during a congressional session Jan. 6. Congress meets in January after each presidential election to certify votes from the Electoral College. Biden beat President Donald Trump 306-232 in the electoral vote in November’s election,

Continue Reading

China approves its first homegrown coronavirus vaccine, developed by Sinopharm

Chinese regulators have approved the country’s first homegrown coronavirus vaccine, developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday. The approval comes a day after Sinopharm said its vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials. China has drastically scaled up its vaccine emergency use program in recent weeks. Since December

Continue Reading

China’s Sinopharm says its coronavirus vaccine is 79% effective

China’s state-owned pharmaceutical giant Sinopharm has announced its coronavirus vaccine is 79.34% effective. Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who received two doses produced high-level antibodies, according to a statement published Wednesday by Beijing Biological Products Institute Co., a Sinopharm subsidiary. The company said it was seeking

Continue Reading